RSS-Feed abonnieren
DOI: 10.1055/a-2462-6667
Platelet Reduction in Rats Exposed to Chronic Hypoxia Is Associated with Interaction of Glycoprotein Ib Alpha von Willebrand Factor
Funding This work was supported by the Sichuan Science and Technology Program (2023YFQ0068); the General Hospital of Western Theater Command (2021-XZYG-C30).

Abstract
Chronic high-altitude hypoxia is associated with reduced platelet count, but it is unclear whether the decrease in platelet count is due to impaired production or increased clearance. This study examines how hypoxia affects platelet production and apoptosis and elucidates the impact of glycoprotein Ibα–von Willebrand factor interaction on platelets in rats using a hypobaric hypoxia chamber. The results showed that the number of megakaryocytes increased under hypoxia; however, the levels of differentiation and polyploidy decreased, while those of apoptosis increased. Platelet production did not reduce according to the reticulated platelet percentage, while platelet apoptosis enhanced; these results suggest that increased platelet clearance was the main reason behind platelet reduction. Our previous microarray results indicated that glycoprotein Ibα (GPIbα) expression increased under hypoxia, which was a protein involved in platelet clearance; therefore, we examined the interaction of platelet GPIbα with the von Willebrand factor (vWF) both in vivo and in vitro to explore the effect of this process on platelets and whether it is related to platelet apoptosis. Under hypoxia, the stronger interaction between GPIbα and vWF promoted platelet apoptosis; inhibiting this interaction reduced platelet apoptosis and increased platelet counts. Platelet reduction is associated with apoptosis induced by the interaction between GPIbα and vWF.
Data Availability
The datasets generated for this study can be found in the figshare database (https://doi.org/10.6084/m9.figshare.23993115).
Authors' Contributions
T.W. and Z.W. conceived and designed the research; Z.W. and D.G. performed the experiments and analysed the data; Z.W. and Y.Y. prepared the figures; Y.Y. assisted in the experiment; Z.W. and D.G. drafted and revised the manuscript; and Y.W. and T.W. approved the final version of the manuscript. Z.W. and D.G. contributed equally to this work and should be considered co-first authors.
* These authors contributed equally to this work and should be considered co-first authors.
Publikationsverlauf
Eingereicht: 13. Juni 2024
Angenommen: 05. November 2024
Artikel online veröffentlicht:
28. März 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G. Platelets and multi-organ failure in sepsis. Int J Mol Sci 2017; 18 (10) 2200
- 2 Scherlinger M, Guillotin V, Truchetet ME. et al. Systemic lupus erythematosus and systemic sclerosis: all roads lead to platelets. Autoimmun Rev 2018; 17 (06) 625-635
- 3 Vardon-Bounes F, Ruiz S, Gratacap MP, Garcia C, Payrastre B, Minville V. Platelets are critical key players in sepsis. Int J Mol Sci 2019; 20 (14) 3494
- 4 Wang Y, Huang X, Yang W, Zeng Q. Platelets and high-altitude exposure: a meta-analysis. High Alt Med Biol 2022; 23 (01) 43-56
- 5 Wang Z, Tenzing N, Xu Q. et al. Apoptosis is one cause of thrombocytopenia in patients with high-altitude polycythemia. Platelets 2023; 34 (01) 2157381
- 6 Saxonhouse MA, Rimsza LM, Stevens G, Jouei N, Christensen RD, Sola MC. Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonates. Biol Neonate 2006; 89 (02) 104-108
- 7 Qi J, You T, Pan T, Wang Q, Zhu L, Han Y. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia. Thromb Haemost 2017; 117 (10) 1875-1886
- 8 Cameron SJ, Mix DS, Ture SK. et al. Hypoxia and ischemia promote a maladaptive platelet phenotype. Arterioscler Thromb Vasc Biol 2018; 38 (07) 1594-1606
- 9 León-Velarde F, Maggiorini M, Reeves JT. et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol 2005; 6 (02) 147-157
- 10 Monge-C C, Arregui A, León-Velarde F. Pathophysiology and epidemiology of chronic mountain sickness. Int J Sports Med 1992; 13 (Suppl. 01) S79-S81
- 11 Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation 2007; 115 (09) 1132-1146
- 12 Vargas E, Spielvogel H. Chronic mountain sickness, optimal hemoglobin, and heart disease. High Alt Med Biol 2006; 7 (02) 138-149
- 13 Stauffer E, Loyrion E, Hancco I. et al. Blood viscosity and its determinants in the highest city in the world. J Physiol 2020; 598 (18) 4121-4130
- 14 Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM. Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet 2000; 356 (9242): 1657-1658
- 15 Cancienne JM, Diduch DR, Werner BC. High altitude is an independent risk factor for postoperative symptomatic venous thromboembolism after knee arthroscopy: a matched case-control study of Medicare patients. Arthroscopy 2017; 33 (02) 422-427
- 16 Jha PK, Sahu A, Prabhakar A. et al. Genome-wide expression analysis suggests hypoxia-triggered hyper-coagulation leading to venous thrombosis at high altitude. Thromb Haemost 2018; 118 (07) 1279-1295
- 17 Ninivaggi M, de Laat M, Lancé MMD. et al. Hypoxia induces a prothrombotic state independently of the physical activity. PLoS One 2015; 10 (10) e0141797
- 18 Tyagi T, Ahmad S, Gupta N. et al. Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype. Blood 2014; 123 (08) 1250-1260
- 19 Nording HM, Seizer P, Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6: 98
- 20 Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients?. Br J Haematol 2017; 177 (01) 27-38
- 21 Delaney C, Davizon-Castillo P, Allawzi A. et al. Platelet activation contributes to hypoxia-induced inflammation. Am J Physiol Lung Cell Mol Physiol 2021; 320 (03) L413-L421
- 22 Khodadi E. Platelet function in cardiovascular disease: activation of molecules and activation by molecules. Cardiovasc Toxicol 2020; 20 (01) 1-10
- 23 Andrews RK, Gardiner EE, Shen Y, Whisstock JC, Berndt MC. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003; 35 (08) 1170-1174
- 24 Zhang Y, Ehrlich SM, Zhu C, Du X. Signaling mechanisms of the platelet glycoprotein Ib-IX complex. Platelets 2022; 33 (06) 823-832
- 25 Shang C, Wuren T, Ga Q. et al. The human platelet transcriptome and proteome is altered and pro-thrombotic functional responses are increased during prolonged hypoxia exposure at high altitude. Platelets 2020; 31 (01) 33-42
- 26 Chen M, Yan R, Zhou K. et al. Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia. Proc Natl Acad Sci U S A 2018; 115 (45) E10682-E10691
- 27 Quach ME. GPIb-IX-V and platelet clearance. Platelets 2022; 33 (06) 817-822
- 28 China Health Law, Detailed Rules for the Administration of Medical Experimental Animals, 03. 1998: 39–41
- 29 Aldashev AA, Sarybaev AS, Sydykov AS. et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am J Respir Crit Care Med 2002; 166 (10) 1396-1402
- 30 Nijiati Y, Shan L, Yang T, Yizibula M, Aikemu A. A 1H NMR spectroscopic metabolomic study of the protective effects of irbesartan in a rat model of chronic mountain sickness. J Pharm Biomed Anal 2021; 204: 114235
- 31 Yang M, Zhu M, Song K. et al. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway. Life Sci 2021; 266: 118873
- 32 Gao X, Zhang Z, Li X. et al. Macitentan attenuates chronic mountain sickness in rats by regulating arginine and purine metabolism. J Proteome Res 2020; 19 (08) 3302-3314
- 33 Denis MM, Tolley ND, Bunting M. et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122 (03) 379-391
- 34 Rondina MT, Schwertz H, Harris ES. et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost 2011; 9 (04) 748-758
- 35 Fidler TP, Campbell RA, Funari T. et al. Deletion of GLUT1 and GLUT3 reveals multiple roles for glucose metabolism in platelet and megakaryocyte function. Cell Rep 2017; 20 (04) 881-894
- 36 Lefrançais E, Ortiz-Muñoz G, Caudrillier A. et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 2017; 544 (7648): 105-109
- 37 Dusse LMS, Freitas LG. Clinical applicability of reticulated platelets. Clin Chim Acta 2015; 439: 143-147
- 38 Harrison P, Robinson MS, Mackie IJ, Machin SJ. Reticulated platelets. Platelets 1997; 8 (06) 379-383
- 39 Matic GB, Rothe G, Schmitz G. Flow cytometric analysis of reticulated platelets. Curr Protoc Cytom 2001; Chapter 7: 10
- 40 De Silva E, Kim H. Drug-induced thrombocytopenia: focus on platelet apoptosis. Chem Biol Interact 2018; 284: 1-11
- 41 Mason KD, Carpinelli MR, Fletcher JI. et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128 (06) 1173-1186
- 42 Thushara RM, Hemshekhar M, Basappa, Kemparaju K, Rangappa KS, Girish KS. Biologicals, platelet apoptosis and human diseases: an outlook. Crit Rev Oncol Hematol 2015; 93 (03) 149-158
- 43 Zhang H, Nimmer PM, Tahir SK. et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 2007; 14 (05) 943-951
- 44 Gyulkhandanyan AV, Mutlu A, Freedman J, Leytin V. Markers of platelet apoptosis: methodology and applications. J Thromb Thrombolysis 2012; 33 (04) 397-411
- 45 Deng W, Xu Y, Chen W. et al. Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor. Nat Commun 2016; 7: 12863
- 46 Hartley PS, Savill J, Brown SB. The death of human platelets during incubation in citrated plasma involves shedding of CD42b and aggregation of dead platelets. Thromb Haemost 2006; 95 (01) 100-106
- 47 Li J, van der Wal DE, Zhu G. et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun 2015; 6: 7737
- 48 Quach ME, Chen W, Li R. Mechanisms of platelet clearance and translation to improve platelet storage. Blood 2018; 131 (14) 1512-1521
- 49 Quach ME, Dragovich MA, Chen W. et al. Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets. Blood 2018; 131 (07) 787-796
- 50 Yan R, Chen M, Ma N. et al. Glycoprotein Ibα clustering induces macrophage-mediated platelet clearance in the liver. Thromb Haemost 2015; 113 (01) 107-117
- 51 Savage B, Saldívar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84 (02) 289-297
- 52 Li S, Wang Z, Liao Y. et al. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost 2010; 8 (02) 341-350
- 53 Casari C, Du V, Wu YP. et al. Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia. Blood 2013; 122 (16) 2893-2902
- 54 Lillicrap D. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Hematology (Am Soc Hematol Educ Program) 2013; 2013: 254-260
- 55 Sanders WE, Read MS, Reddick RL, Garris JB, Brinkhous KM. Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model. Lab Invest 1988; 59 (04) 443-452
- 56 Chen W, Liang X, Syed AK. et al. Inhibiting GPIbα shedding preserves post-transfusion recovery and hemostatic function of platelets after prolonged storage. Arterioscler Thromb Vasc Biol 2016; 36 (09) 1821-1828
- 57 Liang X, Russell SR, Estelle S. et al. Specific inhibition of ectodomain shedding of glycoprotein Ibα by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost 2013; 11 (12) 2155-2162
- 58 Gangarosa EJ, Landerman NS, Rosch PJ, Herndon Jr EG. Hematologic complications arising during ristocetin therapy; relation between dose and toxicity. N Engl J Med 1958; 259 (04) 156-161
- 59 Gitz E, Koekman CA, van den Heuvel DJ. et al. Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts. Haematologica 2012; 97 (12) 1873-1881
- 60 Vij AG. Effect of prolonged stay at high altitude on platelet aggregation and fibrinogen levels. Platelets 2009; 20 (06) 421-427
- 61 Erslev AJ. Megakaryocytic and erythrocytic cell lines share a common precursor cell. Exp Hematol 1994; 22 (02) 112-113
- 62 Rolović Z, Basara N, Biljanović-Paunović L, Stojanović N, Suvajdzić N, Pavlović-Kentera V. Megakaryocytopoiesis in experimentally induced chronic normobaric hypoxia. Exp Hematol 1990; 18 (03) 190-194
- 63 Birks JW, Klassen LW, Gurney CW. Hypoxia-induced thrombocytopenia in mice. J Lab Clin Med 1975; 86 (02) 230-238
- 64 Falcieri E, Bassini A, Pierpaoli S. et al. Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec 2000; 258 (01) 90-99
- 65 Sanz C, Benet I, Richard C. et al. Antiapoptotic protein Bcl-x(L) is up-regulated during megakaryocytic differentiation of CD34(+) progenitors but is absent from senescent megakaryocytes. Exp Hematol 2001; 29 (06) 728-735
- 66 Li J, Kuter DJ. The end is just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol 2001; 74 (04) 365-374
- 67 Denis CV, Lenting PJ. von Willebrand factor: at the crossroads of bleeding and thrombosis. Int J Hematol 2012; 95 (04) 353-361
- 68 Lazzari MA, Sanchez-Luceros A, Woods AI, Alberto MF, Meschengieser SS. Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis. Hematology 2012; 17 (Suppl. 01) S150-S152
- 69 Sun S, Urbanus RT, Ten Cate H. et al. Platelet activation mechanisms and consequences of immune thrombocytopenia. Cells 2021; 10 (12) 3386
- 70 Cheung CL, Ho SC, Krishnamoorthy S, Li GHY. COVID-19 and platelet traits: a bidirectional Mendelian randomization study. J Med Virol 2022; 94 (10) 4735-4743
- 71 Grieb P, Swiatkiewicz M, Prus K, Rejdak K. Hypoxia may be a determinative factor in COVID-19 progression. Curr Res Pharmacol Drug Discov 2021; 2: 100030
- 72 Paterson GG, Young JM, Willson JA. et al. Hypoxia modulates platelet purinergic signalling pathways. Thromb Haemost 2020; 120 (02) 253-261
- 73 Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology 2021; 88 (01) 15-27
- 74 Kiers D, Tunjungputri RN, Borkus R. et al. The influence of hypoxia on platelet function and plasmatic coagulation during systemic inflammation in humans in vivo . Platelets 2019; 30 (07) 927-930
- 75 Kiouptsi K, Gambaryan S, Walter E, Walter U, Jurk K, Reinhardt C. Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation. Sci Rep 2017; 7 (01) 7621
- 76 Gong PH, Dong XS, Li C. et al. Acute severe asthma with thyroid crisis and myasthenia: a case report and literature review. Clin Respir J 2017; 11 (06) 671-676
- 77 Humbert M, McLaughlin V, Gibbs JSR. et al; PULSAR Trial Investigators. Sotatercept for the treatment of pulmonary arterial hypertension. N Engl J Med 2021; 384 (13) 1204-1215
- 78 Rahimi-Rad MH, Soltani S, Rabieepour M, Rahimirad S. Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2015; 83 (05) 348-351